Crosslinking and Fulguration in the Treatment of Acanthamoebic Keratitis
https://doi.org/10.18008/1816-5095-2020-4-725-732
Abstract
Purpose: to study the combined Photo-Activated Chromophore for Keratitis — Corneal Cross-Linking (PACK-CXL) in combination with fulguration of the infiltration zone in the treatment of medically refractive acanthamoebic keratitis.
Patients and methods. The study included 9 patients (10 eyes) with medically refractive acanthamoebic keratitis. The diagnosis was confirmed by confocal microscopy data from a microbiological study of scraping of corneal tissue from the lesion site with Romanovsky-Giemsa stain. All patients underwent combined surgical treatment of PACK-CXL with pre-fulguration. Optical coherence tomography (OCT) of the anterior segment of the eye was also performed using an RTVue-100 apparatus (Optovue USA), determination of visual acuity, photographing before and after surgery.
Results. In 6 cases (60 %), a positive effect was noted, relief of the symptoms of the disease and the formation of turbidity within a month after the procedure, as well as an increase in the maximum corrected visual acuity. According in vivo confocal microscopy, 6 months after the intervention, no signs of infection were detected. In 4 cases, the therapeutic effect was absent. Subsequently, 3 patients (3 eyes) underwent therapeutic keratoplasty. In one eye, the infectious process was stopped medically for 6 months.
Conclusion. The combined PACK-CXL method together with fulguration can be effective and safe in the treatment of medically refractive acanthamoebic keratitis, allowing keratoplasty to be performed with an optical goal if necessary, after stopping the infection process in a distant period.
About the Authors
S. V. Trufanov
Research Institute of Eye Diseases
Russian Federation
Russian Federation
MD, head of the reconstructive surgery of the eye anterior segment department,
Rossolimo str., 11А, В, Moscow, 119021
A. V. Zaitsev
Research Institute of Eye Diseases
Russian Federation
Russian Federation
PhD, junior research associate of the reconstructive surgery of the eye anterior segment department,
Rossolimo str., 11А, В, Moscow, 119021
N. P. Shakhbazyan
Research Institute of Eye Diseases
Russian Federation
Russian Federation
postgraduate,
Rossolimo str., 11А, В, Moscow, 119021
References
1. Wollensak G., Spoerl E., Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620– 627. DOI: 10.1016/S0002-9394(02)02220-1
2. Kolli S., Aslanides I.M. Safety and efficacy of collagen crosslinking for the treatment of keratoconus. Expert Opin Drug Saf. 2010;9:949–957. DOI: 10.1517/14740338.2010.495117
3. Gkika M., Labiris G., Kozobolis V. Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: A review of clinical and experimental studies. Int Ophthalmol. 2011;31:309–319. DOI: 10.1007/s10792-011-9460-x
4. Tsugita A., Okada Y., Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103(2):360–363. DOI: 10.1016/0005-2787(65)90182-6
5. Goodrich R.P., Edrich R.A., Li J., Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci. 2006;35(1):5–17. DOI: 10.1016/j.tran sci.2006.01.007
6. Marschner S., Goodrich R. Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfusion Medicine and Hemotherapy. 2011;38(1):8–18. DOI: 10.1159/000324160
7. Ruane P.H., Edrich R., Gampp D., Keil S.D., Leonard R.L., Goodrich R.P. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004;44:877–885. DOI: 10,1111 /j.15372995.2004.03355.x
8. Reddy H.L., Dayan A.D., Cavagnaro J., Gad S., Li J., Goodrich R.P. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev. 2008;22:133–153. DOI: 10.1016/j.tmrv.2007.12.003
9. Iseli H.P., Thiel M.A., Hafezi F., Kampmeier J., Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590–594. DOI: 10.1097/ICO.0b013e318169d698
10. Hafezi F., Randleman J.B. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg. 2014;30(7):438–439. DOI: 10.3928/1081597X-20140609-01
11. Khan Y.A., Kashiwabuchi R.T., Martins S.A., Castro-Combs J.M., Kalyani S., Stanley P., Behrens A. Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis. Ophthalmology. 2011;118(2):324–331. DOI: 10.1016/j.ophtha.2010.06.041
12. Garduño-Vieyra L., Gonzalez-Sanchez C.R., Hernandez-Da Mota S.E. Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report. Case reports in ophthalmology. 2011;2(2):291–295. DOI: 10.1159/000331707
13. Berra M., Galperin G., Boscaro G. Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea. 2013;32:174–178. DOI: 10,1097/ICO.0b013e31825cea99
14. del Buey M.A., Cristobal J.A., Casas P. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol. 2012;153:399–404. DOI: 10.1016/j.ajo.2011.07.025
15. Lamy R., Chan E., Good S.D., Cevallos V., Porco T.C., Stewart J.M. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Exp Ophthalmol. 2016;44:181–187. DOI: 10.1111/ceo.12644
16. Kashiwabuchi R.T., Carvalho F.R., Khan Y.A. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Investig Ophthalmol Vis Sci. 2011;52:9333–9338. DOI:10.1167/iovs.11-8382
17. Kandori M., Inoue T., Shimabukuro M., Hayashi H., Hori Y., Maeda N., Tano Y. Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. Cornea. 2010;29(10):1199–1202. DOI: 10.1097/ICO.0b013e3181d3d674
18. Maychuk D.Yu., Chilingaryan L.B., Kishkin Yu.I., Maychuk N.V. Phototherapeutic keratectomy in case of acanthameba keratitis. Fyodorov Journal of Ophthalmic Surgery = Oftal’mokhirurgiya. 2010;(6):51–54 (In Russ.).
19. Cheng Z., Xuguang S., Zhigun W., Ran L. In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol. 2008;92:1283–1286. DOI: 10.1136 /bjo.2007.134288
20. Binder P.S. Cryotherapy for medically unresponsive acanthamoeba keratitis. Cornea. 1989:8:106–114.
Review
For citations:
Trufanov S.V., Zaitsev A.V., Shakhbazyan N.P. Crosslinking and Fulguration in the Treatment of Acanthamoebic Keratitis. Ophthalmology in Russia. 2020;17(4):725-732. (In Russ.) https://doi.org/10.18008/1816-5095-2020-4-725-732
Views:
1388
Email this article 